moneyheap
RVTY · Analysis updated Nov 3, 2026, 10:35 AM ET
Why is Revvity, Inc. (RVTY) stock moving?
Revvity sells lab instruments, research software and diagnostic tests. Its third-quarter profit beat forecasts, margins jumped, and it raised its full-year growth outlook. The stock rose about 11% to around $169, a new 52-week high.
News behind the analysis
- Revvity stock rises 5% on strong earnings beat and raised guidanceAdjusted EPS $1.37 vs $1.30; revenue $729M vs about $695M; 2026 adjusted EPS guide $5.40-5.45.
- Revvity (NYSE:RVTY) Jumps Pre-Market as Q3 EPS Beat and Margin Expansion Overshadow In-Line RevenueEPS beat about 4%; pro forma revenue in line; full-year revenue guide about 2% below consensus; margin up about 260bp.
- Revvity Q3 2026 slides: strong growth, margin expansion lift outlookOrganic growth outlook raised to about 5% from 4-5%; margin about 28.8%; AI-related demand spreading across the portfolio.
- Earnings call transcript: Revvity tops Q3 2026 estimates and lifts outlookQ4 segment outlook; 2027 and AI to be discussed at the November 13 Investor Day.
- Revvity Q3 2026 Earnings: Margins Expand as Guidance RisesRepaid $571M of notes; long-term debt about $2.63B; China IDX sale expected by end of 2027.
In the Daily Standout
- November 3, 2026: on the shortlist +11.20%